RxDoctor Payments Data

Eric Chenworth, DO

Allergy & Immunology · Riverton, UTNPI 1700859907

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Sanofi at 16.2% of the total. That places this record below the midpoint for allergy & immunology clinicians in UT, where the typical reported total is $1,434.

$124in general payments, 2019–2025

Across 7 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$20
  • Genentech USA, Inc.$20
  • Blueprint Medicines Corporation$20
  • Incyte Corporation$18
  • Hikma Pharmaceuticals USA$17
  • Novartis$15
  • plus $15 from 1 others
$90,550in research payments, 2019–2025

Across 5 payments — averaging $18,110 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$91K

What the payments were for

  • Food & beverage$124100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$124 in reported general payments places this provider in the 15th percentile of 30 allergy & immunology providers in Utah.

See all allergy & immunology providers in Utah

Medicare billing

Part B allowed, 2024
$20,195
Medicare patients
26
Services billed
1,311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Riverton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →